Multipool-CEST and CEST-based pH assessment as predictive tools for glioma grading, IDH mutation, 1p/19q codeletion, and MGMT promoter methylation in gliomas
CEST-based tumor pH assessment and metabolic profiling demonstrated promising potential for predicting glioma grade, IDH mutation status, 1p/19q codeletion, and MGMT genotype.
Authors
- Zuo‐Lin Xiang (ORCID: https://orcid.org/0000-0002-5725-842X)
- Jue Lu (ORCID: https://orcid.org/0000-0002-9873-439X)
- Xiaoming Liu (ORCID: https://orcid.org/0000-0002-8353-570X)
- Xiaoxiao Zhang (ORCID: https://orcid.org/0000-0002-8566-2147)
- Xiaotong Guo (ORCID: https://orcid.org/0000-0002-4039-613X)
- Qian Qin (ORCID: https://orcid.org/0009-0009-3934-9772)
- Peng Sun (ORCID: https://orcid.org/0000-0002-5918-3935)
- Xinli Zhang (ORCID: https://orcid.org/0000-0002-9458-3985)
- Lan Cheng
- Jing Wang (ORCID: https://orcid.org/0000-0002-3793-3264)
Institutions
- Philips (China) (CN)
- Wuhan Union Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-12-20
- DOI
- https://doi.org/10.3389/fonc.2024.1507335
- Citations
- 4
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.75
Funders
- National Natural Science Foundation of China